Lymphomas Non-Hodgkin's B-Cell
8 clinical trials · Condition
◉ Watch Lymphomas Non-Hodgkin's B-Cell
| Record | Firm | Date |
|---|---|---|
| ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) (NCT04049513) | Malaghan Institute of Medical Research | 2019-10-11 |
| Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma (NCT03379493) | Eureka Therapeutics Inc. | 2018-04-04 |
| Long-term Follow-up Study of Patients Receiving CAR-T Cells (NCT03375619) | Medical College of Wisconsin | 2017-12-01 |
| Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study (NCT03244176) | Austin Health | 2017-07-21 |
| CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma (NCT03029338) | Institute of Hematology & Blood Diseases Hospital, China | 2017-06-08 |
Track Lymphomas Non-Hodgkin's B-Cell automatically
Every clearance here is in the API, with alerts when new ones post.